Adar1 Capital Management, LLC Blueprint Medicines Corp Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 5,100 shares of BPMC stock, worth $444,720. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,100Holding current value
$444,720% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$583 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$580 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$470 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$346 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$241 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.21B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...